Medical News
Addiction
Allergies
Alternative Medicine
Asthma
Cancer
Cardiology
Chiropractic
Dental
Dermatology
Diabetes
Emergency
Family Medicine
General
Geriatrics
Hospitals
Infectious Diseases
Internal Medicine
Managed Care / HMO
Medical Products
Mental Health
Neurology
Nursing
Nutrition
OB / GYN
Pediatrics
Pharmaceuticals
Physical Therapy
Plastic Surgery
Psychology
Radiology / Imaging
Research
Sports Medicine
Surgery
Vision
Recent Advances in Organic Chemistry Using Real-Time In Situ FTIR  - 18 Jan, 2009
Organic Chemistry case studies illustrating the value of in situ mid IR reaction monitoring for facilitating a fundamental knowledge of chemical reactions

Law Firm Freedland Russo Spearheads Record-Setting Whistleblower Case Against...  - 16 Jan, 2009
Florida based law firm of Freedland Russo publicly revealed the law firm that initiated the nation's largest federal whistleblower case to date, which was unsealed in Philadelphia on Thursday, January 15. As part of a settlement with the U.S. Attorney's Office, Eli Lilly & Company will pay out $1.4 billion in civil and criminal fines related to its illegal and fraudulent marketing of the highly profitable prescription drug Zyprexa.

ClearTrial to Provide Guidelines for Accurately Forecasting and Budgeting...  - 15 Jan, 2009
ClearTrial will examine solutions to the budgeting, forecasting, and operational planning challenges presented by adaptive studies. These challenges include creating multiple and varied trial scenarios accounting for shifting resource allocations, timelines, treatment arms, and more.

360e Productions Advances While Production Agency Conglomerates Struggle  - 15 Jan, 2009
This is a difficult economy, no doubt, but 360e Production's virtual, open business model proves to be an aggressively progressive new approach that is solid and successful, despite industry challenges, translating to value for clients.

Teledyne Tekmar Welcomes SCI-CON to its Family  - 15 Jan, 2009
Teledyne Tekmar Company, a subsidiary of Teledyne Technologies Incorporated (NYSE:TDY) announces their latest sales partnership.

SARMs... The Benefits Of Anabolic Steroids, Without The Common Side Effects,...  - 15 Jan, 2009
While they're banned by several doping agencies, most athletes have never heard of them. Selective Androgen Receptor Modulators (SARMs), which are currently undetectable, may be the performance enhancers of the future.

Ash Stevens Enhances Speed and Safety of Scale-Up with New Investments in...  - 14 Jan, 2009
Ash Stevens Incorporated (ASI), a full service cGMP contract manufacturer, enhanced the speed and safety of scale-up with new investments in parallel synthesis and calorimetry instrumentation at its Riverview, Michigan Active Pharmaceutical Ingredient (API) development and manufacturing site.

The Deal Magazine's Deal Economy Preview Reveals Pressure Centers in Today's...  - 14 Jan, 2009
The magazine's cover story examines how the woes of residential real estate may soon be joined by their brethren on the commercial side

Liaison Technologies Strengthens Its Presence in Europe with New Subsidiaries  - 13 Jan, 2009
Liaison Technologies, a global provider of integration and data management services, announced today the expansion of its European operations to the UK and Sweden, where the company is opening new subsidiaries. The European business integration and data management service market is growing fast and the UK and Sweden are key markets for Liaison. Setting up new subsidiaries is an important step for the expansion of Liaison's European and international operations. The company already has offices in Finland and the Netherlands as well as significant coverage in US markets with global...

Datafarm, Inc., Announces the Appointment of Daniel F. Orfe to Vice...  - 13 Jan, 2009
Datafarm, Inc. a leading provider of Electronic Document Publishing Solutions and Regulatory Submissions Services for the Life Sciences Industry, is pleased to announce the appointment of Mr. Daniel F. Orfe to Vice President, Global Regulatory Submission Services (GRSS). In this role, Mr. Orfe will oversee Datafarm's Regulatory Services Group.
1 2 3 4 5 Next page
Home Terms of Use Privacy Policy Contact Us